D
uring recent years, it has become increasingly evident that arterial smooth muscle cells occur in at least two distinct states, usually referred to as a synthetic and a contractile phenotype. Synthetic-state cells have a fibroblast-like appearance, and their main functions are to proliferate and to produce extracellular matrix components. They are found in the embryo and the young growing organism, where they take part in the formation of the vessel wall. Contractile-state cells have a musclelike appearance and contract in response to chemical and mechanical stimuli. They predominate in the vessels of adults and are primarily involved in the control of blood pressure and flow. However, these cells are able to return to a synthetic phenotype, and this appears to be an important early event in atherogenesis. This review briefly summarizes the present knowledge concerning the regulation of differentiated properties and proliferation of arterial smooth muscle cells. Most of the discussion will deal with studies on cultured cells, which so far are the most abundant. Particular attention will be paid to the role of extracellular matrix components like fibronectin and laminin and of polypeptide mitogens like platelet-derived growth factor (PDGF). It is believed that future studies in this area will help to widen our understanding of vasculogenesis and the initial stages in the pathogenesis of atherosclerosis.
Development of Arterial Smooth Muscle Cells
In the embryo, the large arteries arise from the mesoderm.
1 2 3 Mesenchymal cells initially form a lining of endothelial cells around spaces filled with fluid. Subsequently, additional mesenchymal cells accumulate and start to differentiate into smooth muscle cells. The signals that control this process are largely unknown. During most of the fetal and early postnatal period, the smooth muscle cells have a fibroblast-like appearance with an extensive rough endoplasmic reticulum, a prominent Golgi complex, and only a few myofilaments. 45 They proliferate and secrete extracellular matrix components like collagen and elastin. 678 At this stage, /3-actin is the main actin isoform and vimentin is the main intermediate filament protein. 9 - 12 Later on, as the vessels mature, the synthetic organelles decrease in size and myofilaments occupy successively larger parts of the cytoplasm. 45 This is associated with a decrease in the synthetic and proliferative activities, and instead the ability to contract is established. In parallel, there is a decreased /3-actin expression and an increased expression of smooth muscle-specific a-actin. 9 ' 101113 Moreover, the content of the intermediate filament protein desmin and the fraction of cells that show a positive staining for both vimentin and desmin increase. 9141516 There is also a distinct rise in the cellular content of myosin and tropomyosin. 91718 In adults, the arterial media is made up of highly differentiated smooth muscle cells arranged in concentric layers. 1920 Each cell is encircled by a basement membrane composed of collagen type IV, laminin, entactin (nidogen), and heparan sulfate proteoglycans. 21 - 24 This macromolecular network plays an important role in the homeostasis of the cells by direct interaction with them, by regulating the transport of molecules to and from them, and by establishing a link with the surrounding extracellular matrix. The latter is primarily made up of elastic laminae, 2526 fibrils of collagen type I and III, 2728 and chondroitin sulfate and dermatan sulfate proteoglycans. 2930 In short, the above changes in structure and function of arterial smooth muscle cells during development can be referred to as a shift from a synthetic to a contractile phenotype (Figure 1 ). To a large extent, this process resembles the conversion of proliferating myoblasts into postmitotic myotubes during the formation of striated muscle. 31 However, in contrast to these cells, the smooth muscle cells are able to return from a contractile to a synthetic phenotype. Most prominently, this takes place in connection with atherogenesis and when smooth muscle cells are established in culture. 3233 Since the cells appear to be able to shift back and forth between these states and do not return to a multipotential state, it has been suggested that the process should be referred to as phenotypic modulation rather than dedifferentiation. 33 In the following, we use the term phenotypic modulation to describe some major variations in cellular 
Modulation of Smooth Muscle Phenotype during Atherogenesis
For a general survey of the atherosclerotic process, the reader is referred to recent reviews. 34 - 37 In the early stages of the disease, smooth muscle cells migrate from the media to the intima of the arterial wall, where they proliferate and deposit extracellular matrix components, thereby forming a lesion that protrudes into the vessel lumen. Immunocytochemical studies with cell type-specific monoclonal antibodies have indicated that the lesions also contain numerous macrophages and T lymphocytes. 38 - 42 It is believed that a damage to the endothelial barrier may initiate the process. The smooth muscle cells are thus under the influence of a large variety of factors, not only blood components but also substances released by endothelial cells, platelets adhering to exposed subendothelial tissue, as well as macrophages and T lymphocytes invading the vessel wall. In addition, the smooth muscle cells may produce and release substances that affect their own function.
Electron microscopic studies have revealed that the smooth muscle cells in atherosclerotic lesions are modified structurally, with a decrease in the content of myofilaments and an increase in the size of the rough endoplasmic reticulum and the Golgi complex. Likewise, structural and functional changes indicating a modulation of the smooth muscle cells from a contractile to a synthetic phenotype have been observed in experimental animals after induction of intimal lesions by balloon catheterization. 4647 ' 48 The shift in differentiated properties of the smooth muscle cells during atherogenesis and experimental lesion formation is also reflected in the expression of cytoskeletal proteins. In both cases, there is a switch from smooth muscle-specific a-actin to /3-actin 49 - 53 and a decrease in the expression of smooth muscle myosin. 54 Moreover, the expression of desmin decreases, 5556 whereas the cells start to express low levels of cytokeratins. 57 Another sign of a changed smooth muscle phenotype during atherogenesis and experimental lesion formation is the expression of class II transplantation antigens. 5859 ' 60 Further, monoclonal antibodies have been produced that react with surface antigens present on smooth muscle cells in intimal lesions but not in the normal media.
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In Vitro Cultivation as Experimental System to Study Regulation of Smooth Muscle Phenotype
Because of the great complexity of the in vivo environment, cell culture has become an important model for studies on the control of smooth muscle phenotype and proliferation. The main advantage of cell culture is the possibility to set up defined conditions and to study the effects of individual factors without the complex interplay with other cell types and without the hormonal and neuronal influences that exist in the intact organism. The first attempts to culture smooth muscle were made in the beginning of this century. 6364 However, it was not until the early 1970s that this technique became well established. From then on, it has found use in a large number of investigations and has been described in recent reviews. 6566 In this section, we will mainly deal with the shift in phenotype of adult arterial smooth muscle cells in primary culture.
Cellular Fine Structure
Fritz et al. 67 were the first to point out that during the first few days in primary culture arterial smooth muscle cells change from a muscle-like to a fibroblast-like morphology and that this precedes the onset of cellular proliferation. Similar findings were subsequently made in studies on smooth muscle cells from experimental animals as well as humans. 68 - 71 In short, the following sequence of events is observed (see Figure 1) . Cells isolated by enzymatic digestion of the arterial media have a heterochromatic nucleus and a cytoplasm dominated by bundles of myofilaments coalescing in dense bodies and abundant mitochondria (Figure 2A ). Initially, these cells adhere to the bottom of the culture dishes and then spread out over a period of a few days. At the same time, Figure 2 . Changes in fine structure during phenotypic modulation in primary culture. Smooth muscle cells were isolated enzymatically from the media of rat aorta, were grown in plastic dishes in nutrient medium containing 10% serum, and were fixed for transmission electron microscopy after varying times. A. Freshly isolated cell with a heterochromatic nucleus (N) and a cytoplasm dominated by myofilament bundles (F) and mitochondria ( M ) -a contractile phenotype. B. Two-day-old culture. Numerous free polyribosomes (R) and cisternae of rough endoplasmic reticulum (RER) appear in the perinuclear cytoplasm. Myofilament bundles (F) remain in the more peripheral cytoplasm-an intermediate stage. C. Four-day-old culture. Euchromatic nucleus (N) and a cytoplasm dominated bycisternae of rough endoplasmic reticulum (RER) and a large juxtanuclear Golgi complex (G) -a synthetic phenotype. Bars=0.5 fim.
there is an extensive reorganization of the cytoskeleton with loss of myofilament bundles and formation of actincontaining stress fibers and radiating networks of microtubules and intermediate filaments. 72 Moreover, cisternae of rough endoplasmic reticulum grow out from the nuclear envelope and a large juxtanuclear Golgi complex is formed. 70 In this way, a successive rebuilding of the cytoplasm occurs ( Figures 2B and 2C ). This process was found to take place independently of whether the culture medium is supplemented with whole blood serum or with plasma-derived serum.
Cytoskeletal Markers
As part of the phenotypic modulation of arterial smooth muscle cells, there is a characteristic shift in the expression of actin. The a-isoform predominates in freshly isolated, contractile cells, but increased amounts of the /3-isoform, as well as noticeable amounts of the y-isoform, are found in synthetic cells. 4973 - 77 At least partly, this appears to be due to changes in actin mRNA levels. 527778 However, both in primary cultures and in passaged cells, the control of actin expression is still incompletely understood. It depends on growth rate as well as cell density and evidently includes both transcriptional/posttranscriptional and translational/ posttranslational events. 75777980 Although some variation in the published results exists, the main conclusion is that smooth muscle a-actin mRNA and protein synthesis are suppressed during the phenotypic modulation and in actively proliferating cultures and increase again as the cultures become confluent and cell replication ceases. For the main part, nonmuscle /3-actin behaves in the opposite way. In any case, smooth muscle a-actin is a marker for vascular smooth muscle cells not only in primary cultures but also in subcultures and in established cell lines. 81 - 92 On the other hand, it is not a good tool to distinguish smooth muscle cells in a contractile phenotype from cells in a synthetic phenotype. In other cytoskeletal components, the phenotypic modulation in primary culture is associated with a distinctly decreased expression of smooth muscle myosin and an increased expression of nonmuscle myosin; as in the case of actin, the expression of myosin is also influenced by the density and growth state of the cultures. 3393 - 97 The cellular content of tropomyosin decreases 7498 and the content of desmin decreases, whereas the content of vimentin increases. 7499 These changes in cytoskeletal composition are all indicative of a change from a highly differentiated smooth muscle phenotype to a more fibroblast-like phenotype.
Activation of Synthetic and Secretory Functions
In parallel with the structural transformation of the smooth muscle cells in primary culture, overall RNA and protein synthesis and cellular proliferation are activated. 67 - 72 Moreover, synthesis and secretion of extracellular matrix components like collagen, elastin, and proteoglycans are enhanced.
100101102 Type I is the main collagen species produced, together with smaller amounts of type III and V. Immunocytochemical studies have indicated that the smooth muscle cells further secrete laminin and type IV collagen and surround themselves with a basement membrane-like layer.
100 Neonatal smooth muscle cells, which are already in a synthetic phenotype in vivo, have likewise been described as secreting collagen, elastin, and proteoglycans in primary culture.
103 - 106 As outlined in previous reviews, all these macromolecules are also produced by subcultured smooth muscle cells.
25 -
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Lipid Metabolism
Studies on rabbit aortic smooth muscle cells in primary culture have demonstrated that the modulation into a synthetic phenotype is associated with increased binding and degradation of very low density lipoprotein (VLDL) and increased binding of low density lipoprotein (LDL); in both cases, the binding appeared to be mediated via the apolipoprotein (apo) B/E receptor. 108109 Conceivably, this reflects an increased need of cholesterol and other lipid components for membrane synthesis in the growing and rapidly proliferating synthetic-state cells. In an investigation on subcultured rat aortic smooth muscle cells, it was found that cells containing only vimentin accumulated more LDL than cells containing both vimentin and desmin. On the other hand, there was no difference in ingestion of LDL between cells containing and those lacking smooth muscle a-actin. Cells cultured in the presence of 10% serum took up more LDL than cells cultured in the presence of 1% serum. 110 These results support the idea that the ability of smooth muscle cells to ingest and metabolize lipoproteins is correlated with their phenotypic state and replicative activity.
Role of Extracellular Matrix Components
As mentioned above, it was noted that the phenotypic modulation of arterial smooth muscle cells in primary culture takes place equally well in media containing whole blood serum or plasma-derived serum. 6970 This suggested that one or several plasma components may be involved. When exploring this possibility, it was found that a substrate of the plasma protein fibronectin efficiently promotes the transition of rat aortic smooth muscle cells from a contractile to a synthetic phenotype during primary culture in a serum-free medium. findings confirm the notion that the phenotypic modulation is a necessary, but not sufficient, requirement for smooth muscle proliferation in vitro.
6970 Moreover, they demonstrate that it is possible to study the change in overall differentiated properties and the onset of cell proliferation separately. The results agree with the established role of fibronectin in cell attachment and spreading and in supporting the ability of cells to respond to growth factors and proliferate.
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The power of fibronectin to bring about the change in phenotype of the smooth muscle cells was shown to reside in the cell-binding domain of the molecule, whereas the collagen-and heparin-binding domains were inactive in this respect. 112 Further, the transition of the cells into a synthetic phenotype was distinctly slower on substrates of laminin and type IV collagen, two major components of the basement membrane that normally surrounds smooth muscle, 21 -24 than on a substrate of fibronectin. 112 However, with time an increasing proportion of the cells turned into a synthetic phenotype, apparently due to endogenous secretion of fibronectin. In support of this conclusion, it was found that cells cultured on laminin produced more fibronectin than cells cultured on fibronectin. 112 This suggests that the cells are able to sense the macromolecular composition of the pericellular matrix and to adjust their biosynthetic activities thereafter. Similar conclusions have been drawn in studies on subcultured cells. 117 Next, it was demonstrated that the interaction between the smooth muscle cells and fibronectin is mediated via a cell surface receptor belonging to the integrin superfamily of proteins (for reviews, see references [113] [114] [115] [116] [118] [119] [120] [121] and the minimal cell-attachment sequence of fibronectin, Arg-Gly-Asp (RGD). 122123 Cells seeded on a substrate of an RGD-containing peptide (GRGDSC) attached and spread equally well as cells seeded on a substrate of the cell-binding domain of fibronectin or of intact fibronectin. Likewise, the overall change in cell morphology proceeded at similar rates on the three substrates. These processes were all distinctly slowed down by antibodies against the /3, integrin subunit (this antibody interfered with the attachment of the cells to fibronectin but not to vitronectin, another adhesive plasma protein that contains an RGD sequence). 122 The fibronectin receptors of the smooth muscle cells were isolated by sequential chromatography on columns of wheat germ agglutinin (WGA) and the cell-binding domain of fibronectin. 123 They were composed of two proteins with electrophoretic mobilities in sodium dodecyl sulfate (SDS)-polyacrylamide gels of 160 and 115 kDa under nonreducing conditions and of 150 and 130 kDa under reducing conditions. Subsequent immunochemical and immunocytochemical studies have indicated that these molecules correspond to the 05-and /3,-subunits of the fibronectin receptor (unpublished observations). 124 The receptor molecules are arranged in linear arrays on the cell surface. They are co-aligned with, and presumably establish a transmembrane linkage between, fibronectin fibrils in the pericellular matrix and actin filament bundles in the cytoplasm. 120124 During primary culture on a substrate of fibronectin, the receptors seem to primarily interact with bundles of nonmuscle actin. At the same time, the cells do not express mRNA for smooth muscle a-actin, but the level of this actin isoform decreases only slowly, showing a partly diffuse staining in the cytoplasm. In subcultures, smooth muscle a-actin is again incorporated in actin filament bundles co-aligned with fibronectin receptors in the plasma membrane. differentiated properties of arterial smooth muscle cells. Fibronectin promotes conversion of the cells from a contractile to a synthetic phenotype, whereas laminin acts in the opposite direction (Figure 3 ). There also exists circumstantial evidence indicating a role for fibronectin in the control of smooth muscle phenotype in vivo. In the chick embryo, fibronectin was found to appear before laminin in forming blood vessels, and the expression of laminin was suggested to be an early indicator of vascular maturation. 125 Further, increased amounts of fibronectin appear in early atherosclerotic lesions. 126 - 131 Similar observations have been made in studies on the development of skeletal muscle. Fibronectin promotes proliferation of myoblasts and inhibits terminal differentiation and myotube formation, whereas laminin has the reverse effect. 132133 ' 134 In addition, the synthesis and distribution of fibronectin and laminin changes during myogenesis.
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The mechanisms of action behind the effects described above are not known. In part, adhesive molecules exert their effect by organization of the actin cytoskeleton. It is evident how this could explain the attachment and spreading of the cells on the substrate. 113 - 116 It has also been suggested that extracellular matrix components may influence gene expression via the effect on cell shape. 140141142 However, it is not clear how the contact with a fibronectin substrate brings about the extensive overall structural and functional reorganization of the smooth muscle cells. Moreover, there are evidently distinct differences in the effects of different extracellular matrix components. Although a substrate of laminin supported attachment and spreading of the smooth muscle cells, its effect on cellular phenotype was opposite to that of fibronectin. 112 Therefore, cell shape alone is unlikely to be responsible. The elucidation of the signal transduction system that mediates the effect of extracellular matrix components on the differentiated properties of cells remains a challenge for the future.
Although few experimental data are available to date, several other adhesive proteins may be important in the control of smooth muscle phenotype.
143144 These include vitronectin, a 75 kDa glycoprotein found in blood plasma and tissues. 145146 This molecule contains an RGD sequence but binds to a cell surface receptor distinct from the fibronectin receptor, 147 and supports attachment and spreading of freshly isolated smooth muscle cells less efficiently than fibronectin. 122 Thrombospondin is a 450 kDa trimeric glycoprotein stored in platelet a-granules and released during platelet degranulation. It is synthesized by a number of normal and transformed cells in culture and shows binding affinities for a variety of plasma and extracellular matrix proteins. 148 - 151 As discussed further below, this molecule has so far mainly been studied in relation to smooth muscle cell proliferation. Preliminary experiments suggest that it is not a good attachment substrate for these cells (unpublished observations). Tenascin is a large hexameric glycoprotein of the extracellular matrix, especially prominent during embryonic development and in tumors. 152153 Among others, it has been found to interfere with the action of fibronectin. 154155 Initial immunocytochemical studies show that tenascin is distinctly . Subcultured rat aortic smooth muscle cells were detached by trypsinization and were reseeded in serum-free medium on substrates of fibronectin (A) or laminin plus type IV collagen (B, C). After two days of culture, the cells were fixed in buffered glutaraldehyde and were processed for transmission electron microscopy. The cells cultured on fibronectin are distinguished by an extensive rough endopiasmic reticulum (RER) and a large Golgi complex (G). After culture on the substrate of laminin plus type IV collagen, myofilament bundles (F) are more prominent. L=lysosomes, M=mitochondria, N=nucleus. Bars=0.5 fim.
expressed both in cultured arterial smooth muscle cells and in intimal lesions induced by balloon catheterization (unpublished observations).
Other major components of the extracellular matrix may also be of importance in this context. The structure and function of smooth muscle cells cultured on or within a collagen gel was altered.
156 -159 Moreover, the differentiated properties and growth of smooth muscle cells were changed after inhibition of proteoglycan synthesis by treatment with /3-D-xyloside. 160 It has been suggested that heparin and heparan sulfate proteoglycans in the basement membrane of endothelial and smooth muscle cells inhibit the modulation of smooth muscle cells from a contractile to a synthetic phenotype in primary cul-ture. 161162 However, it is difficult to distinguish the effects on overall phenotypic properties and proliferation of the cells in these studies (see further below). We have not observed any distinct effect of heparin on the fine structural transformation of arterial smooth muscle cells in primary culture (unpublished observations).
Role of Prostaglandins and Leukotrienes
Numerous macrophages are found in atherosclerotic lesions. 38 - 42 These cells synthesize and release a large number of biologically potent molecules including growth factors, interleukins, hydrolytic enzymes, and adhesive glycoproteins. 163164 They also represent a major source of prostaglandins and leukotrienes. These substances are formed from arachidonic acid via the cyclooxygenase and lipoxygenase pathways, respectively, and play important roles in allergic reactions and inflammation. 165 -171 They are believed to exert their effects via specific receptors, and receptor antagonists are explored as potential therapeutic agents. 172 - 175 Considerable interest has been paid to the role of these substances in cardiovascular disease.
176 -181 However, so far only a few studies have directed attention to their influence on the phenotypic state and proliferation of arterial smooth muscle cells.
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Prostaglandin E, (PGE,), which shares many biological properties with prostaglandin l 2 (PGI 2 ), was found to accelerate the transition of rat aortic smooth muscle cells from a contractile to a synthetic phenotype early in primary culture as registered electron microscopically.
183
As a result, there was an earlier onset of serum-induced DNA synthesis and mitosis in PGE,-treated than in control cultures. However, once the cells had entered a synthetic phenotype, PGE, inhibited DNA synthesis and cell proliferation (see below). In addition, metabolites of PGI 2 were demonstrated to stimulate cholesteryl ester degradation in cultured arterial smooth muscle cells. 184185 More recently, it was shown that leukotriene B 4 (LTB 4 ), C 4 (LTC 4 ), D 4 (LTD 4 ), and E 4 (LTE 4 ) all speed up the transition of rat aortic smooth muscle cells into a synthetic phenotype in primary culture.
186 Similar results were obtained with cells seeded on a plastic surface in serum-containing medium and cells seeded on a substrate of fibroneclin in serum-free medium. Furthermore, LTB 4 , LTC 4 , and LTD 4 stimulated the cells to enter the cell cycle earlier than in the controls (see below). These findings demonstrate that prostaglandins and leukotrienes are able to potently affect the differentiated state of arterial smooth muscle cells. The mechanisms of action are still unknown.
Role of Polyamines
The polyamines putrescine, spermidine, and spermine represent a group of ubiquitous, low molecular weight cations that are important in the control of cell differentiation and proliferation. 187188189 The major rate-limiting steps in the synthesis of polyamines are the reactions catalyzed by ornithine decarboxylase (ODC) and S-adenosylmethionine decarboxylase (SAMDC). The two main substances used to block these enzymes are a-difluoromethylornithine (DFMO), a catalytic and irreversible inhibitor of ODC, and methylglyoxal-to/s(guanylhydrazone) (MGBG), a reversible and competitive inhibitor of SAMDC. 187188189 In a study on rat aortic smooth muscle cells, the modulation from a contractile to a synthetic phenotype was found to be associated with activation of polyamine metabolism. 190 ODC activity increased to a maximum after 2 days of culture and was accompanied by a successive rise in the cellular concentrations of putrescine, spermidine, and spermine. Treatment of the cultures with the polyamine synthesis inhibitors, DFMO and MGBG, distinctly slowed down the transition of the cells into a synthetic phenotype, as judged by following the fine structural reorganization of the cells and the onset of cellular proliferation. 190 As further discussed below, these drugs also inhibit the induction of DNA synthesis in subcultured smooth muscle cells by PDGF.
191
In addition, DFMO has been found to interfere with the proliferation and subsequent differentiation of myoblasts.
192
Remodulation from a Synthetic to a Contractile Phenotype
In studies on rabbit and pig aortic smooth muscle, it was observed that the phenotypic modulation is reversible if the cells are seeded at a high initial density and a confluent monolayer is formed within less than 1 week of proliferation. 109161 This was seen as an increase in the fractional volume occupied by myofilaments and in the expression of smooth muscle a-actin mRNA as the cultures became confluent. 77 In studies on rat aortic smooth muscle cells cultured in the presence of serum, signs of reentry into a contractile phenotype at confluence have been more scarce. 707475 However, preliminary experiments with subcultured cells detached with trypsin and reseeded in serum-free medium on substrates of fibronectin or laminin plus type IV collagen suggest that a partial remodulation may be possible (unpublished observations). On fibronectin, the percentage of cells with stress fibers stained for smooth muscle a-actin was low (Figure 4A ), and the cells had a fine structure characteristic of a synthetic phenotype ( Figure 5A ). On laminin plus type IV collagen, there was an increase in the fraction of cells with smooth muscle a-actin positive stress fibers ( Figure 4B ), and distinct myofilament bundles reappeared in central parts of the cytoplasm ( Figures 5B and 5C ). These findings emphasize the importance of extracellular matrix components in the control of the differentiated properties of vascular smooth muscle cells (see above).
In Vitro Cultivation as Experimental System to Study Regulation of Smooth Muscle Proliferation
It is today widely recognized that smooth muscle cell proliferation is a major etiologic event in the formation of atherosclerotic lesions. 34 - 37 Since the early stages in the disease cannot be followed in humans, most in vivo studies have been made on naturally occurring or experimentally induced lesions in animals.
193 Autoradiography with tritiated thymidine was used to demonstrate that after mechanical injury of the endothelium, medial smooth muscle cells migrate into the intima and replicate. 194195196 However, it is difficult to study the regu- Adult rat aortic smooth muscle cells (second or third passage) were grown to sub-confluence on glass coverslips, were incubated in serum-free medium for 48 hours, and were exposed to the indicated human recombinant polypeptide mitogens (basic FGF=bovine, recombinant) at different concentrations and for different times in the presence of tritiated thymidine. After fixation, the cultures were processed for autoradiography, and the percentage of labeled nuclei was determined. The results are presented as the approximate means of a series of experiments.
C max =concentration where maximum effect is reached. Lag phase=time between mitogen addition and onset of DNA synthesis. PDGF=platelet-derived growth factor, FGF=fibroblast growth factor, EGF=epidermal growth factor, IGF-l=insulin-like growth factor-l, IL-1=interleukin-1, TGF-/3=transforming growth factor beta.
lation of smooth muscle proliferation in vivo, and most of the literature in this field refers to in vitro systems.
Induction of Cell Proliferation by Polypeptide Mitogens
Like most other nontransformed cells, smooth muscle cells do not normally multiply in culture in the absence of serum. Ross and collaborators 197198199 demonstrated that the active component in serum is of platelet origin. Similar observations were made on fibroblasts and glial cells. 200201 Thereafter, a PDGF was purified and partially characterized. 202 -205 The rapid growth in the knowledge on this mitogen during the following years has been outlined in recent reviews. 206 -211 In short, PDGF is a cationic 30 kDa protein composed of two polypeptide chains (A and B) that give rise to three disulfide-linked dimers (AA, AB, and BB). The A-and B-chains are encoded by separate but related genes, the B-chain gene being identical to the proto-oncogene c-s/s. 212 ' 213214 The different isoforms of PDGF exert their effects on target cells by interaction with high-affinity receptors of at least two types, the a-receptor, which binds either the A-or the B-chain, and the /3-receptor, which binds only the B-chain. 215216 The binding of the ligand to the receptor gives rise to a complex biological response that ultimately leads to DNA replication and cell division.
217218
Vascular smooth muscle cells were among the first cell types shown to have specific receptors for PDGF. 219220221 After binding to the receptors on the cell surface, PDGF is internalized by endocytosis and transferred to lysosomes for degradation. 222223 In parallel, it was demonstrated that serum-starved smooth muscle cells enter the cell cycle, replicate their DNA, and divide in response to PDGF, 220 even under completely serum-free conditions. 224225 Several studies have suggested an interaction between PDGF and insulin-like growth factor-l (IGF-I) in stimulating smooth muscle cell replication, 226227228 and cells stimulated with PDGF were found to produce IGF-I. 229230 However, IGF-I alone appears in most cases to be but a weak mitogen for vascular smooth muscle cells. 226 - 230 More recently, it has been demonstrated that vascular smooth muscle cells have both PDGF a-and /3-receptors and respond mitogenically to all isoforms of PDGF. 231232 At least in subcultured smooth muscle cells, the a-receptors are less numerous than the /3-receptors and the mitogenic response to PDGF-AA is weaker than that to PDGF-AB and PDGF-BB. In addition to its effects on cellular replication, PDGF has been found to stimulate migration of smooth muscle CellS.
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Other polypeptide growth factors of interest here are epidermal growth factor (EGF), 236237238 and fibroblast growth factor (FGF). 239240 Vascular smooth muscle cells have receptors for and respond mitogenically to both of these factors. 241 - 245 Attention has also been paid to interleukin-1 (IL-1), 246247 and transforming growth factor-/? (TGF-/3).
248249 IL-1 was found to stimulate smooth muscle cell proliferation, 250251 apparently via induction of endogenous PDGF production. 252 With regard to TGF-/3, both inhibitory and stimulatory effects have been reported. 253 - 257 Recently, a growth-promoting effect of interleukin-6 (IL-6), a cytokine secreted by monocytes and macrophages, has also been reported. 258 Moreover, it was noted that smooth muscle cells stimulated with IL-1 or PDGF secrete large amounts of IL-6. 259 Our own observations on subcultured rat aortic smooth muscle cells have shown that PDGF-BB is the most potent growth factor, followed by FGF and EGF. On the other hand, PDGF-AA, IGF-I, IL-1, and TGF-/3 have relatively weak effects (Table 1) .
When vascular smooth muscle cells are grown in primary culture in a medium containing whole blood serum, the modulation into a synthetic phenotype is closely associated with the onset of cell proliferation. 67 -71 In the presence of plasma-derived serum or under serum-free conditions, these processes can be studied separately. 6970111112 Preliminary observations on rat aortic smooth muscle cells seeded on a substrate of fibronectin indicate that several growth factors are able to induce DNA synthesis and mitosis under these conditions (unpublished observations). In contrast to the situation in subcultured cells, an equipotent effect is obtained with PDGF-BB and PDGF-AA.
'
112 ' 232 Thus, the mitogenic effect of different isoforms of PDGF may depend on the previous replicative history of the cells. FGF and EGF give less prominent responses, and with IGF-I, TGF-/3, and IL-1 no or only weak effects are seen ( Table 2) .
Production of a Platelet-derived Growth Factor-like Mitogen
In addition to being stimulated by exogenous mitogens, vascular smooth muscle cells have been found to synthesize and secrete growth-promoting agents on their own. First, it was demonstrated that aortic smooth muscle Adult rat aortic smooth muscle cells (freshly isolated) were seeded on a substrate of fibronectin, were incubated in serumfree medium for 5 days, and were exposed to the indicated human recombinant polypeptide mitogens (basic FGF=bovine, recombinant) at different concentrations and for different times in the presence of tritiated thymidine. After fixation, the cultures were processed for autoradiography, and the percentage of labeled nuclei was determined. The results are presented as the approximate means of a series of experiments.
C max =concentration where maximum effect is reached. Lag phase=time between mitogen addition and onset of DNA synthesis. See the legend for Table 1 for an explanation of the abbreviations.
cells from young, but not from adult, rats release a PDGF-like molecule during successive passages in vitro. 260 In parallel, it was observed that adult rat aortic smooth muscle cells directly after the modulation into a synthetic phenotype and initiation of cell proliferation by an exogenous mitogen continue to proliferate in the absence of exogenous mitogen for several days.
70 Subsequently, it was shown that these cells release a PDGFlike molecule into the culture medium at several-fold higher levels than subcultured cells. 261 This was coupled to expression of mRNA for the A-chain but not the B-chain of PDGF, raising the possibility that the mitogen produced by the cells is an A-chain homodimer. 262 Moreover, it was found that smooth muscle cells isolated from intimal lesions developing after balloon catheterization produced several-fold larger amounts of PDGF-like activity than cells isolated from the normal media. 263 It was then shown that aortic smooth muscle cells from newborn and adult rats both express increased levels of PDGF A-chain transcripts in vitro, whereas only cells from newborn rats express increased levels of PDGF B-chain transcripts. Further, cells from newborn rats secreted 60-fold more PDGF-like activity than cells from adult rats. 264 In another study, cell lysates were analyzed, and higher levels of PDGF-like activity were found in cells from old (>19 months) than from young (<3 months) rats.
265
It was also reported that both the PDGF A-and B-chain genes are expressed in rat aorta in vivo and that no major differences occur between normotensive and hypertensive animals. 264266 Likewise, PDGF A-and B-chain transcripts were found in the normal human artery wall as well as in atherosclerotic lesions, 267268269 and smooth muscle cells isolated from human atheroma express PDGF A-chain mRNA and secrete a PDGF-like mitogen. 270 Human umbilical vein smooth muscle cells bind and respond to all isoforms of PDGF (AA<AB<BB) and secrete PDGF-AA-like material. 231 In partial contrast to these findings, cultured nonhuman primate (baboon) aortic smooth muscle cells were observed to transcribe both the PDGF A-and B-chain genes, but did not secrete detectable amounts of PDGF-like activity. 271 Using the primary culture system described above, with cells seeded on a substrate of fibronectin in serum-free medium, we have explored the production of PDGF-like material by rat aortic smooth muscle cells in some further detail. The results indicate that the expression of the PDGF A-chain gene increases as the cells go through the transition from a contractile to a synthetic phenotype. At the same time, PDGF receptor activity increases, but no detectable amounts of PDGF-like material are released into the medium, and the cells do not start to replicate until they have been exposed to exogenous PDGF. 272 Moreover, it was noted that the expression of PDGF a-and /3-receptor mRNA increases in association with the phenotypic modulation, and that the cells specifically bind all isoforms of PDGF (AA<AB<BB).
232 Subsequent studies suggest that PDGF is the most potent inducer of endogenous PDGF production, although other growth factors may have a similar effect (unpublished observations); studies on passaged cells have indicated that angiotensin II and TGF-/3 stimulate the expression of PDGF A-chain mRNA and secretion of PDGFlike molecules. 273274 Several observations suggest that endogenous PDGF production is associated with autocrine or paracrine stimulation of cell replication. After the initial exposure to PDGF, there is a high rate of initiation of DNA synthesis in primary cultures for several days in the absence of exogenous stimuli, whereas a rapid return to baseline levels is seen in subcultures. 232 However, neither antibodies against PDGF nor suramin, a polyanionic drug that inhibits cellular binding of PDGF, 275 interferes with the initiation of DNA replication in the primary cultures. 276 These findings raise the possibility that the mitogen produced by the smooth muscle cells acts intracellularly, without prior release into the pericellular space.
Production of Other Polypeptide Mitogens
As mentioned earlier, cultured vascular smooth muscle cells produce IGF-I as part of the response to PDGF. 230 Human smooth muscle cells were shown to produce IL-1 when exposed to bacterial endotoxin or IL-1, 277 . 278 Human and bovine smooth muscle cells have also been found to express and respond to acidic and basic FGF, respectively.
244245 Moreover, after stimulation with several hormones and growth factors, human smooth muscle cells secrete the mitogenic peptide endothelin (see below). 279 Recently, a new growth factor distinct from PDGF and other previously described mitogens, was demonstrated to be produced by cultured rabbit smooth muscle cells after four passages or more.
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Role of Vasoactive Hormones
Studies on subcultured vascular smooth muscle cells have indicated that catecholamines like epinephrine and norepinephrine, potent vasoconstrictors in vivo, stimulate proliferation in the presence of serum and that the effect is mediated via oadrenergic receptors. 282283284 In a recent in vivo study, it was further demonstrated that a-adrenergic agonists stimulate expression of the PDGF A-chain gene as well as other growth-related genes in rat aortic smooth muscle. 285 In this context, it is interesting to note that growth factors like PDGF and EGF have been found to induce contraction of rat aortic strips. 286287288 These findings suggest that the biological response of vascular smooth muscle to catecholamines and polypeptide mitogens depends on the phenotypic state of the cells; cells in a contractile phenotype are stimulated to contract and cells in a synthetic phenotype are stimulated to divide. Serotonin, a neurotransmitter and a substance released from degranulating platelets, was likewise observed to stimulate smooth muscle cell replication. 289 Angiotensin II, another potent vasoconstrictor, appears to be an exception from this rule. It binds to receptors on cultured vascular smooth muscle cells, 290291 and stimulates several steps in the signal transduction machinery for growth factors and hormones. 292293294 Nonetheless, angiotensin II has not been found to stimulate proliferation of vascular smooth muscle cells, neither alone nor in combination with serum or PDGF, but gives rise to an increased protein synthesis and cellular hypertrophy. 295296 It has further been demonstrated that neuropeptides promote proliferation of vascular smooth muscle and other cells.
297298 Substance P and substance K (neurokinin A) were shown to stimulate initiation of DNA synthesis in serum-starved rat aortic smooth muscle cells and human skin fibroblasts, and to add to the effect of a low concentration of PDGF. 299 In a similar manner, a growthpromoting effect of substance P was observed in an established line of embryonic rat aortic smooth muscle cells. 300 Subsequently, it was found that the response to substance K is dependent on the level of expression of the myc gene, possibly indicating that substance K alone is not able to induce all signals necessary for a mitogenic response.
301 Anyhow, substance P and substance K both stimulate formation of inositol phosphates in smooth muscle cells. 302 Recently, considerable interest has also been focused on endothelin, a potent vasoconstrictor peptide produced by vascular endothelial cells.
303 -306 Endothelin binds specifically to human vascular smooth muscle cells in culture, 307308 and stimulates expression of the protooncogenes c-fos and c-myc as well as phospholipase C-mediated hydrolysis of phosphoinositides.
308 " 312 It was found to act as a mitogen for rat aortic smooth muscle cells, 309310313 and to stimulate induction of DNA synthesis in mouse 3T3 fibroblasts. 314315 Endothelin is thus another example of a substance with the dual function to stimulate vascular smooth muscle cells in a contractile phenotype to contract and cells in a synthetic phenotype to divide.
Role of Prostaglandins and Leukotrienes
During recent years, increasing interest has been directed to the possible role of prostaglandins and leukotrienes in the control of cell proliferation. 182316317 Studies on cultured A10 smooth muscle cells revealed that EGF stimulates PGI 2 production if there is a concurrent stimulus that raises intracellular Ca 2+ levels. 340 In conclusion, these observations suggest that endogenous prostaglandins modulate the cellular response to PDGF and other growth factors.
Studies in our laboratory have indicated that leukotrienes may also play an important role in the regulation of smooth muscle proliferation. As mentioned above, LTB 4 , LTC 4 , LTD,,, and LTE 4 all stimulate the conversion of rat aortic smooth muscle cells from a contractile to a synthetic phenotype early in primary culture. Moreover, LTB 4 , LTC 4 , and LTD 4 enhance the proliferative response to serum mitogens and, under serum-free conditions, induce DNA synthesis in newly modulated cells by themselves. 186 In addition, LTB 4 , LTC 4 , and LTD 4 induce DNA synthesis in subcultured rat aortic smooth muscle cells in the absence of other mitogens. 341 Treatment of the cells with indomethacin or acetylsalicylic acid, two cyclooxygenase inhibitors, blocked induction of DNA synthesis by LTB 4 , suggesting that its effect is mediated by a cyclooxygenase product. Indirect support for this possibility was provided by the observation that the prereplicative lag phase is 6 to 8 hours longer with LTB 4 than with PDGF. The maximum effect of the leukotrienes was about half of that obtained with PDGF, and at suboptimal concentrations of PDGF, an additive effect of the leukotrienes was obtained. 341 Growth-promoting effects of leukotrienes have also been observed in cultures of glomerular epithelial cells, 3 4 2 3 4 3 epidermal keratinocytes, 344 fibroblasts, 345 and endothelial cells. 346 In recent experiments, we have continued to examine the growth-stimulatory effect of LTB 4 on rat aortic smooth muscle cells, with particular emphasis on the role of endogenous cyclooxygenase products (unpublished observations). The results reveal that arachidonic acid, PGF 2a , PGE 2 , and PGI 2 all are able to induce DNA synthesis under serum-free conditions and in the absence of other mitogens. When given together with PDGF, PGE 2 and PGI 2 showed an inhibitory effect, whereas PGF 2a lacked any distinct effect. DNA synthesis could also be induced with hydroxyeicosatetraenoic acids (HETEs), products derived from arachidonic acid primarily via the lipoxygenase pathway. 347 The most prominent effect was seen with 15-HETE, which in rat aortic smooth muscle cells can be produced via the cyclooxygenase pathway. 348 Radioimmunologic analyses indicated that the smooth muscle cells are able to produce PGF 2m PGE 2 , PGI 2 , and 15-HETE and that the production is blocked by indomethacin. Moreover, induction of DNA synthesis by conditioned media from smooth muscle cells exposed to LTB 4 was inhibited by antibodies against PDGF (unpublished observations). Taken together, these findings suggest that the growth-promoting effect of LTB 4 may be mediated coordinately by prostaglandins, HETEs, and PDGF produced by the smooth muscle cells themselves. In studies on murine smooth muscle cells, treatment with LTD 4 was found to be associated with increased phospholipase A 2 activity and production of prostaglandins.
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Role of Polyamines
As mentioned above, it has long been recognized that polyamines play a crucial role in the control of cell differentiation and proliferation.
187188189 However, few studies have dealt with the effects of pure growth factors on polyamine metabolism in cultured cells. In an investigation on rat aortic smooth muscle cells, we found that PDGF causes an increase in ODC activity and a rise in the cellular content of putrescine. 191 The inhibitor DFMO blocked the increase in ODC activity as well as the accumulation of putrescine. Moreover, DFMO inhibited induction of DNA synthesis by PDGF without affecting the length of the prereplicative lag phase. This effect was counteracted by the addition of polyamines to the culture medium, and exogenous polyamines were found to stimulate the initiation of DNA synthesis in PDGF-free medium (spermine>spermidine>putrescine). On the basis of these findings, it is concluded that induction of ODC and putrescine synthesis are integral parts in the mitogenic response of smooth muscle cells to PDGF. 191 In parallel, it was observed that exposure of quiescent mouse 3T3 fibroblasts to PDGF induced ODC activity and that treatment of the cells with DFMO inhibited the effect of the mitogen on DNA synthesis.
350351 -3S2 Other growth factors, like FGF and EGF, have also been found to induce ODC activity in fibroblastic cells.
352353
Role of Cytoskeleton
Microtubules and actin filaments are the two major components of the cytoskeleton in mammalian cells and fulfill important functions in the control of cell shape, motility, and intracellular transport. Furthermore, these structures play crucial roles during cell division; microtubules build up the mitotic spindle that separates the chromosomes, 354 and actin filaments take an active part in the division of the cytoplasm during cytokinesis. 355 Distinct changes in the organization of the cytoskeleton have been observed in cells stimulated with growth factors. EGF caused actin reorganization and membrane ruffling in responsive cells.
356357 Similar findings were subsequently made with PDGF, 358 - 361 and the response appeared to be mediated via the /3-receptor. 362 Studies on vascular smooth muscle cells have indicated that PDGF, but not EGF or IGF-I, causes a rapid and reversible disappearance of the protein vinculin from adhesion plaques as well as a disruption of actin filament bundles. 363 These changes may be important for the stimulation of cell motility and cell division, which both require detachment of the cells from the substrate.
With regard to microtubules, clearcut alterations in intracellular organization have been more difficult to demonstrate in connection with the early stages of growth factor stimulation. Nevertheless, a large number of studies indicate that treatment of cells with microtubuledisruptive drugs like colchicine or colcemid either potentiate or inhibit the effect of growth factors on initiation of DNA synthesis, or in some cases even stimulate initiation of DNA synthesis on their own. 364 - 367 In a study on rat aortic smooth muscle cells, a stimulatory effect of colchicine on induction of DNA synthesis was observed in serum-free medium and in the presence of plasmaderived serum. On the other hand, a weak inhibitory effect was obtained in cells exposed to PDGF or whole blood serum. 368 These findings suggest that partial microtubule disassembly may be an inherent step in the processes that lead the cells through the G, and into the S phase of the cell cycle.
Role of Extracellular Matrix Components
Numerous investigations have emphasized the role of extracellular matrix components in the control of vascular smooth muscle proliferation in culture. An extracellular matrix produced by endothelial cells was found to promote the growth and increase the life span of bovine aortic smooth muscle cells. 241 Subsequently, it was observed that heparan sulfate produced by endothelial cells or smooth muscle cells, as well as heparin, inhibits smooth muscle cell proliferation. 161 . 369 -3 74 Heparin was likewise found to suppress in vivo proliferation of smooth muscle cells in injuried arteries. 375 - 378 Structural studies indicated that heparin's antiproliferative activity depends on oligosaccharide size and charge, but not on anticoagulant activity. 379380 Heparin binds to cells and is ingested by endocytosis. 381382383 It affects several steps in the transition of the cells from the G o to the S phase of the cell cycle and may have multiple targets for its antiproliferative effect. 384 -387 Heparin has been reported to modulate the secretion of major proteins by cultured smooth muscle cells, including two 35 to 40 kDa proteins, a 60 kDa collagen, and thrombospondin. 388 - 391 In addition, a 78 kDa heparin-binding protein involved in the inhibition of smooth muscle cell proliferation was described. 392 Stimulation of smooth muscle cells with PDGF was found to induce synthesis and secretion of thrombospondin, an extracellular matrix glycoprotein that acts synergistically with EGF to promote entrance into the S phase of the cell cycle; heparin inhibited the effect of thrombospondin on EGF-induced mitogenesis as well as the incorporation of thrombospondin in the extracellular matrix. 393394395 The effect of heparin on smooth muscle cell proliferation does not appear to be mediated solely by decreased availability or activity of PDGF. 396 The antiproliferative effect of heparin can be reversed by EGF, 397 and heparin and heparin-like molecules were found to regulate the number of EGF receptors on vascular smooth muscle cells. 398 It was also noted that cultured smooth muscle cells from spontaneously hypertensive rats are less susceptible than are cells from control rats to growth inhibition by heparin.
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Role of Protein Phosphorylation, Phosphatidylinositol Turnover, and Ion Fluxes
The binding of PDGF and other polypeptide mitogens to their receptors elicits a cascade of biological responses, 400 including protein phosphorylation, 401402403 phosphatidylinositol turnover, 404 -408 ion fluxes, 409 -412 and increased expression of specific genes. 413414415 It is still unclear exactly how these reactions relate to each other and to the final result of the stimulation, i.e., DNA synthesis and mitosis. In any case, they represent possible targets through which the various factors discussed above may act to influence cell proliferation.
The PDGF and EGF receptors are protein kinases that phosphorylate themselves and a number of other cellular proteins on tyrosine residues. Recent studies on mutated receptors have indicated that this activity is required to evoke a full mitogenic response. 217218416 The phosphate groups added to the proteins are in most cases rapidly removed by a group of enzymes referred to as protein tyrosine phosphatases. 417418 Since cells must be exposed to the growth factors for prolonged periods of time in order to enter the S phase, 419420 it is possible that the receptors have to be activated more than once to be effective. In this context, it is interesting to note that ions of vanadium, an inhibitor of protein tyrosine phosphatases, stimulate growth of fibroblastic cells. 421422 In studies on rat aortic smooth muscle cells, we have observed similar effects. Addition of vanadium ions (10 /iM) to serum-starved cultures induced DNA synthesis in a smaller fraction of the cells. Moreover, the response to low concentrations of PDGF (<5 ng/ml) and to short exposures to PDGF (<10 hours) was distinctly enhanced by vanadium ions (unpublished observations). Although other mechanisms of action cannot be excluded, these findings support the idea that protein tyrosine phosphorylation is an important step in the stimulation of smooth muscle cell proliferation.
Growth factors and other agonists bring about hydrolysis of phospoinositides (minor phospolipids present in all eukaryotic cells) by phospholipase C. This gives rise to two important second messengers: inositol trisphosphate that mobilizes calcium ions from intracellular storage sites and diacylglycerol that activates protein kinase C, an enzyme that phosphorylates proteins on serine and threonine residues. 404 - 408 A possible mechanism of action was revealed when PDGF was found to induce an association of phospholipase C-y with the PDGF receptor complex as well as tyrosine phosphorylation of the enzyme. 423424 However, studies on vascular smooth muscle cells have indicated that phosphoinositide breakdown is neither sufficient nor necessary for a mitogenic response. Both mitogenic and nonmitogenic agonists stimulate phosphoinositide hydrolysis.
292293425 ' 426427 Moreover, there is not always a good correlation between the growth-promoting effect of PDGF and its effect on phosphoinositide hydrolysis. 426427 In any case, smooth muscle cell proliferation is to some extent dependent on the calcium ion concentration of the extracellular medium, 428 and calcium antagonists have been found to inhibit induction of DNA synthesis by PDGF as well as PDGFinduced degradation of phosphoinositides. 426429430431 Interestingly, it was recently observed that PDGF stimulates the association of phosphatidylinositol-3'-kinase with the PDGF receptor complex and that this leads to production of novel phosphoinositides, which may take part in mediating the mitogenic effect of PDGF. 432433 Activation of cell proliferation is also associated with Na + /H + exchange over the plasma membrane and a temporary alkalinization of the cytoplasm, but the functional significance of this event remains unclear. 409 - 412 In vascular smooth muscle cells, agents with, as well as without, growth-promoting effect have been shown to activate Na + /H + exchange, leading to a biphasic shift in cytoplasmic pH. 434 - 438 As previously reported for fibroblastic cells, 409 -412 amiloride (an inhibitor of the Na + /H + exchanger) was found to potently block induction of DNA synthesis by PDGF or serum in rat aortic smooth muscle cells (unpublished observations). Therefore, it seems likely that Na7H + exchange and cytoplasmic alkalinization play at least a permissive role in smooth muscle proliferation.
Perspectives and Summary
In the adult organism, arterial smooth muscle cells are in a highly differentiated, contractile phenotype. However, they have the potential to revert to a synthetic phenotype, similar to that prevailing in the embryo and the young growing organism. This leads to the cells losing their contractility and instead gaining the ability to secrete extracellular matrix components and divide, and this is an important early event in atherogenesis. Based on the ex- perimental data presented in this review, we propose a simplified model for the regulation of differentiated properties and proliferation of arterial smooth muscle cells (Figure 6) . The basement membrane, a sheet-like network made up of laminin, type IV collagen, and heparan sulfate proteoglycans, normally helps to keep the cells in a contractile phenotype. If this barrier is damaged, the plasma membrane may interact with other macromolecules derived from the blood or produced locally by the cells in the vessel wall. Adhesive glycoproteins such as fibronectin bind to integrin receptors on the cell surface and induce a transition of the cells from a contractile to a synthetic phenotype. This process includes loss of myofilaments and formation of an extensive rough endoplasmic reticulum and a large Golgi complex, organelles which take part in the synthesis and secretion of extracellular matrix components. In parallel, there is a reduced expression of o-actin mRNA, and the cells start to express PDGF a-and /3-receptors as well as mRNA for the A-chain of PDGF. In response to stimulation with exogenous PDGF (AA, AB, or BB), the cells replicate their DNA and divide. Moreover, they start to produce PDGF (AA) on their own, which helps them to continue to proliferate in the absence of exogenous mitogen for a limited number of generations. Growth-promoting agents may be derived from the blood, degranulating platelets, leukocytes invading the vessel wall, or endothelial cells. Among these agents, polypeptide mitogens, vasoactive hormones, prostaglandins, and leukotrienes are the most important ( Table 3 ). This simplified model can be used as a framework for future studies on the regulation of differentiated properties and proliferation of arterial smooth muscle cells during in vitro cultivation as well as during atherogenesis. It also suggests possible ways in which to interfere pharmacologically with the phenotypic modulation and the subsequent proliferation of the smooth muscle cells. 
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